Abstract:Extracellular vesicles are nanoparticles produced by cells. They are composed of cellular membrane with associated membrane proteins that surrounds an aqueous core containing soluble molecules such as proteins and nucleic acids, like miRNA and mRNA. They are important in many physiological and pathological processes as they can transfer biological molecules from producer cells to acceptor cells. Preparation of the niche for cancer metastasis, stimulation of tissue regeneration and orchestration of the immune response are examples of the diverse processes in which extracellular vesicles have been implicated. As a result, these vesicles have formed a source of inspiration for many scientific fields. They could be used, for example, as liquid biopsies in diagnostics, as therapeutics in regenerative medicine, or as drug delivery vehicles for transport of medicines. In this Account, we focus on drug delivery applications.As we learn more and more about these vesicles, the complexity increases. What originally appeared to be a relatively uniform population of cellular vesicles is increasingly subdivided into different subsets. Cells make various distinct vesicle types whose physicochemical aspects and composition is influenced by parental cell type, cellular activation state, local microenvironment, biogenesis pathway, and intracellular cargo sorting routes. It has proven difficult to assess the effects of changes in production protocol on the characteristics of the cell-derived vesicle population. On top of that, each isolation method for vesicles necessarily enriches certain vesicle classes and subpopulations while depleting others. Also, each method is associated with a varying degree of vesicle purity and concomitant coisolation of nonvesicular material. What emerges is a staggering heterogeneity. This constitutes one of the main challenges of the field as small changes in production and isolation protocols may have large impact on the vesicle characteristics and on subsequent vesicle activity.We try to meet this challenge by careful experimental design and development of tools that enable robust readouts. By engineering the surface and cargo of extracellular vesicles through chemical and biological techniques, favorable characteristics can be enforced while unfavorable qualities can be overruled or masked. This is coupled to the precise evaluation of the interaction of extracellular vesicles with cells to determine the extracellular vesicle uptake routes and intracellular routing. Sensitive reporter assays enable reproducible analysis of functional delivery.This systematic evaluation and optimization of extracellular vesicles improves our insight into the critical determinants of extracellular vesicle activity and should improve translation into clinical application of engineered extracellular vesicles as a new class of drug delivery systems.

Extracellular Vesicles as Promising Carriers in Drug Delivery: Considerations from a Cell Biologist's Perspective

Extracellular Vesicles as an Efficient and Versatile System for Drug Delivery

Extracellular vesicles as a next-generation drug delivery platform

Drug Delivery with Extracellular Vesicles: From Imagination to Innovation

Extracellular Vesicles as New Players in Drug Delivery: A Focus on Red Blood Cells-Derived EVs

Extracellular vesicles as drug delivery systems: Why and how?

Extracellular Vesicles As an Efficient Nanoplatform for the Delivery of Therapeutics

Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source

Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications

Basic Guide for Approaching Drug Delivery with Extracellular Vesicles

Extracellular vesicles and their therapeutic applications: a review article (part 2)

Extracellular vesicles: Emerging tools as therapeutic agent carriers

Therapeutic Applications of Extracellular Vesicles: Clinical Promise and Open Questions

Extracellular Vesicles as Drug Delivery System for Cancer Therapy

Extracellular vesicles as novel drug delivery systems to target cancer and other diseases: Recent advancements and future perspectives

Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery

Overview and Update on Methods for Cargo Loading into Extracellular Vesicles

Extracellular Vesicles for Drug Delivery in Cancer Treatment

Extracellular Vesicle- and Extracellular Vesicle Mimetics-Based Drug Delivery Systems: New Perspectives, Challenges, and Clinical Developments

Plant-derived extracellular vesicles: a synergetic combination of a drug delivery system and a source of natural bioactive compounds

Extracellular Vesicles as Delivery Systems in Disease Therapy